← Research & Industry News
External source
A two-part nanozyme targets the inflammatory loop linked to colon cancer
By combining an antioxidant nanomaterial with a chemokine-binding cell membrane, researchers have reduced tumor development in mouse models of colitis-associated cancer.
- Published by
- Nanowerk
- Evidence type
- Animal
By combining an antioxidant nanomaterial with a chemokine-binding cell membrane, researchers have reduced tumor development in mouse models of colitis-associated cancer.
This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at Nanowerk.
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.